| Bioactivity | JAK-IN-18 is a potent inhibitor of JAK. JAK-IN-18 is useful for the research of multiple diseases, particularly ocular, skin, and respiratory diseases (extracted from patent WO2018204238A1, compound 1)[1]. |
| Name | JAK-IN-18 |
| CAS | 2247925-32-0 |
| Formula | C27H28F2N6O3 |
| Molar Mass | 522.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Paul R. Fatheree, et al. Fused imidazo-piperidine jak inhibitor compound. Patent WO2018204238A1. |
JAK-IN-18
CAS: 2247925-32-0 F: C27H28F2N6O3 W: 522.55
JAK-IN-18 is a potent inhibitor of JAK. JAK-IN-18 is useful for the research of multiple diseases, particularly ocular,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.